Načítá se...
Prior Authorization of Newer Insomnia Medications in Managed Care: Is It Cost Saving?
STUDY OBJECTIVES: New pharmacotherapeutic treatment options are available to treat patients with 1 or more insomnia symptoms. However, these new Pharmaceuticals are subject to a variety of managed-care tools, such as prior authorizations, that may restrict access to these medications. The objective...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Academy of Sleep Medicine
2007
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1978307/ https://ncbi.nlm.nih.gov/pubmed/17694729 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|